Product Inspection Featured Articles
-
Which Laboratory Software Is The Right One For Your Lab?
7/8/2016
To ensure that your requests for specific software and systems receive full consideration, it pays to fully understand the types of lab management software available.
-
How Do You Inspect Packaging Of Bottles, Cans And Cylinders?
5/13/2016
To ensure the package is error free, progressive companies now use automated proofreading solutions throughout the design and printing of the package and label.
-
Ensuring Bar Code Accuracy From Packaging To The Patient
5/13/2016
For pharmaceutical companies, a barcode helps to assure the origins of the drugs, which in turn helps in minimizing the possibility of a genuine drugs being considered sub-standard or counterfeit.
-
Ensuring Package Seal Integrity For Medical And Healthcare Products
1/21/2016
The way that medical products and devices are packaged and sealed is vital. In fact I don’t think it is an exaggeration to say that it can, literally, be a matter of life and death. That is why regulators around the world apply strict standards to the methods used to package devices and to the testing regimes to ensure that the packaging is properly sealed and that the seal will remain intact while the product is transported and stored. Many countries for example adopt the universally accepted standards devised by ASTM International (formerly the American Society for Testing and Materials).
-
The Versatility Of Charged Aerosol Detection
9/28/2015
Charged Aerosol Detection (CAD) applies to a broad range of HPLC separations and possesses a number of desirable characteristics for detection and quantitation of various compounds including those without UV absorbing chromophores.
-
What’s Really To Blame For Drug Shortages?
6/15/2015
Prescription drug shortages continue to plague the industry and endanger patients. Most experts suggest quality and manufacturing issues are the cause, but are other (more troubling) market dynamics at play?
-
Can Diamond Make Drug Authentication “Flawless?”
5/26/2015
Pharmaceutical industry insiders estimate that more than $350 billion worth of counterfeit drugs are now sold around the world each year. In addition to diverting revenue from manufacturers and distributors, falsified medicines are also putting patients at risk. They are often not manufactured to even minimum quality standards, which can reduce their efficacy. In addition, in many cases they contain dangerous impurities that pose significant safety hazards.
-
USP General Chapter <1207> Revisions: Industry Experts Offer Best Practices To Avoid Destructive, Unreliable Integrity Testing
10/1/2014
The US Pharmacopoeia released a proposed revision to USP General Chapter <1207> Sterile Product Package – Integrity Evaluation for public comment, which focuses on package integrity testing. This chapter is not mandated but does reflect recommended best practices. These changes are necessary to better protect not just the product but also the patient.
-
Molecular Imaging Cuts Time And Cost From Drug Discovery
Everyone involved in drug discovery is seeking ways to lower costs and improve efficiencies. One process that may help pharma and bio firms achieve both goals is molecular imaging (MI). MI is a process which uses imaging platforms, similar in concept to the cameras used to detect white light, to detect the radioactive decay products of a specific radioisotope.
-
Getting Particular About Particulates: How Can You Avoid Becoming The Next Recall?
While there is much speculation about why there has been such an increase in FDA recalls due to the presence of particulate matter in injectables—aging equipment, cleaning deficiencies, discrepancies between regulators, and the list goes on—what companies need to worry about most is how to protect their product and the patient by avoiding this issue altogether. But how?